Clinical Trials Logo
  1. Home
  2. Allergies
  3. NCT00780403

Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)

Allergies Clinical Trial

Official title:
A Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications

Clinical Trial Summary

The primary objective of this study was to determine whether children ages 6-11 years prefer desloratadine RediTabs (2.5 mg) or a marketed competitor (Zyrtec® 5 mg Chewable Tablets). The secondary objectives of this study were to compare acceptance of the two attributes, taste and feeling in the mouth, of desloratadine 2.5 mg RediTabs and Zyrtec® 5 mg Chewable Tablets

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00780403
Study type Interventional
Source Organon and Co
Contact
Status Completed
Phase Phase 4
Start date August 2005
Completion date October 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT01612936 - T Cell Effector and Regulatory Mechanisms in Asthma Phase 1
Completed NCT00779116 - Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) Phase 4
Recruiting NCT06002685 - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention N/A
Completed NCT04644783 - Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES) N/A
Recruiting NCT05635266 - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed NCT01792232 - Effects of Co-Exposure to Air Pollution and Allergen N/A
Completed NCT01454505 - Safety and Efficacy of AL-53817 Nasal Spray Solution Phase 1
Completed NCT00800332 - Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy Phase 2
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Recruiting NCT05119868 - Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring N/A
Completed NCT00801502 - Salmon in Pregnancy Study N/A
Completed NCT00453583 - Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine N/A
Unknown status NCT00892684 - Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease? N/A
Completed NCT00700726 - Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma N/A
Recruiting NCT00350376 - Impact of Asthma Treatments on Daily Activities N/A
Completed NCT00881634 - To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions Phase 1
Completed NCT00881127 - To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions Phase 1
Completed NCT03106493 - Upstate New York Infant Development Screening Program
Completed NCT02017431 - Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction N/A
Completed NCT01711593 - Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma Phase 1